In-Vivo Evaluation of Nebulized Aerosols Delivered Via Nasal Route

Completed · Not applicable

Conditions studied: Interface Acceptance During Delivery of Aerosol Medicine to an Infant or Child

In brief

We hypothesize that infant and children will show different levels of acceptance of different interfaces while they receive inhaled therapy. We also hypothesize that children will exhibit different amounts of time with the aerosol well aligned with the nostrils during transnasal aerosol delivery.

Key facts

Study ID

NCT02082379

Run by

Arkansas Children's Hospital Research Institute

People needed

21

Starts

2014-01-01

Expected to finish

2015-02-01

Last updated by the study team

2016-01-07

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Born at term
• Healthy
• Pacifier user
• Newborn 1-6 week old
• Infants 6-8 month old

You may not qualify if…

• Chronic respiratory disease
• Cardiac disease
• Prematurity
• Neurological disease
• Allergy to Normal Saline
• Allergy to any components of the interfaces

Where it is running

• Arkansas Children's Hospital — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.